Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.

författare

Benjamin Hibbert

Michael Froeschl

Marino Labinaz

Alexander Dick

Jean-François Marquis

Michel R. Le May

Christopher Glover

publicerad i: Clinical Cardiology

utgivningsår: 2016-01-08

språk: engelska

Refererar artiklar 30

Datum

Titel

Författare

2015-05-12

Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients
2014-01-30

One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry

Tuomas Kiviniemi, Paulus Kirchhof, Fausto Biancari, Gregory Y. H. Lip, Andrea Rubboli, Juhani Airaksinen, Pasi P Karjalainen, Axel Schlitt, Matti Niemelä, Saila Vikman
2014-03-20

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study

Benjamin Hibbert, Michael Froeschl, Marino Labinaz, Alexander Dick, Jean-François Marquis, Trevor Simard, Ali Pourdjabbar, Michel R. Le May, Christopher Glover, Ronnen Maze, Melissa Blondeau
2014-06-27

Endovascular cooling catheter related thrombosis in patients undergoing therapeutic hypothermia for out of hospital cardiac arrest.

Benjamin Hibbert, Michael Froeschl, Marino Labinaz, Michel R. Le May
2014-10-28

Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.

Bernhard Witzenbichler, Roxana Mehran, Dariusz Dudek, Ajay J Kirtane, Gregg W Stone, Philippe Généreux, Sorin J. Brener, Thomas McAndrew, Matthew I Tomey, Ran Kornowski, Eugenia Nikolsky, Timothy A Sanborn
2014-02-01

Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists

Deepak L. Bhatt, Christopher P Cannon, Laura Mauri
2014-12-09

Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention

Stephan Windecker, Peter Jüni, Peter Wenaweser, Lorenz Räber, Giulio Stefanini, Bindu Kalesan, Stefan Stortecky, Thomas Pilgrim, Aris Moschovitis, Cédric Pulver, Thomas Zanchin, Heinrich Mattle, Martina Rothenbühler, Simon Jung
2013-03-21

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation

Julinda Mehilli, Adnan Kastrati
2013-07-19

Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting
2012-10-01

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score

Jan Gustav Smith, Emil Rydell
2011-07-25

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.

John W. Eikelboom, David J Moliterno
2011-06-01

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

Adriano Caixeta, Roxana Mehran, Philippe Gabriel Steg, John W. Eikelboom, Marco Valgimigli, Erik Magnus Ohman, Deepak L. Bhatt, Donald E Cutlip, Mitchell Krucoff, Pascal Vranckx, Joseph F Sabik, Harvey D. White, Eugenia Nikolsky, Stephen D Wiviott, Venu Menon
2011-02-01

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment
2010-05-01

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents

John W. Eikelboom
2010-09-01

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Gunnar Hilmar Gislason, Christian Torp-Pedersen, Fredrik Folke, Henrik Enghusen Poulsen, Lars Køber, Steen Z. Abildstrøm, Jakob Raunsø, Niels Gadsbøll, Tina K. Schramm
2010-02-01

Disorders of hemostasis associated with chronic kidney disease
2010-10-01

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Paulus Kirchhof, Paolo Colonna, Frans H Rutten, Piotr Ponikowski, Gregory Y. H. Lip, Dan Atar, Gerhard Hindricks, Isabelle C Van Gelder, Philippe Kolh, Andreas Goette, Hein Heidbuchel, Bulent Gorenek, Jean-Yves Le Heuzey, Raffaele De Caterina, A. John Camm, Nawwar Al-Attar, Irene Savelieva, Sabine Ernst, Bernard D Prendergast, Ottavio Alfieri, Magnus Heldal, Stefan H. Hohloser
2009-09-10

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Hugo A. Katus, Andrzej Budaj, Emmanouil S. Brilakis
2009-12-01

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

Gunnar Hilmar Gislason, Peter Riis Hansen, Christian Torp-Pedersen, Lars Køber, Anders Hvelplund, Charlotte Andersson, Steen Z. Abildstrom, Jan Erik Madsen
2009-11-18

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study

Robert F. Storey, Dean J Kereiakes, Paul A Gurbel
2008-03-01

Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study.

Jean-Claude Tardif
2007-08-14

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

Giuseppe Sangiorgi, Alaide Chieffo, Eberhard Grube, Lutz Buellesfeld, Ulrich Gerckens
2007-11-04

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Eugene Braunwald, Gilles Montalescot, Elliott M Antman, Witold Rużyłło, Carolyn F McCabe, Sabina A Murphy, Stephen D Wiviott, Govinda Weerakkody, Jeffrey R Riesmeyer, TRITON-TIMI 38 Investigators, Shmuel Gottlieb, Diego Ardissino
2007-03

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
2006-05

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Per Morten Sandset, Håkan Emanuelsson
2006-12

Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline

Gregory Y. H. Lip
2006-04-01

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding
2005-05-01

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Giuseppe Sangiorgi, Goran Stankovic, Alaide Chieffo, Eberhard Grube, Ulrich Gerckens
2000-12-15

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
1991-08-01

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

Artikel - wd:Q40988993

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer